PAIM
HBIO icon

Punch & Associates Investment Management’s Harvard Bioscience HBIO Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-25,586
Closed -$14.5K 170
2025
Q1
$14.5K Sell
25,586
-2,730,014
-99% -$1.55M ﹤0.01% 159
2024
Q4
$5.81M Sell
2,755,600
-17,100
-0.6% -$36.1K 0.32% 111
2024
Q3
$7.46M Buy
2,772,700
+361
+0% +$971 0.41% 105
2024
Q2
$7.9M Hold
2,772,339
0.46% 96
2024
Q1
$11.8M Sell
2,772,339
-145,695
-5% -$618K 0.67% 52
2023
Q4
$15.6M Sell
2,918,034
-5,000
-0.2% -$26.8K 0.91% 26
2023
Q3
$12.6M Buy
2,923,034
+60,385
+2% +$260K 0.81% 30
2023
Q2
$15.7M Sell
2,862,649
-84,680
-3% -$465K 0.96% 27
2023
Q1
$12.4M Buy
2,947,329
+183,290
+7% +$770K 0.8% 36
2022
Q4
$7.66M Buy
2,764,039
+40,568
+1% +$112K 0.5% 87
2022
Q3
$6.97M Buy
2,723,471
+69,224
+3% +$177K 0.49% 86
2022
Q2
$9.56M Buy
2,654,247
+188,837
+8% +$680K 0.67% 48
2022
Q1
$15.3M Buy
2,465,410
+298,635
+14% +$1.85M 0.87% 25
2021
Q4
$15.3M Buy
2,166,775
+545,000
+34% +$3.84M 0.8% 31
2021
Q3
$11.3M Sell
1,621,775
-52,537
-3% -$367K 0.65% 50
2021
Q2
$13.9M Sell
1,674,312
-38,555
-2% -$321K 0.79% 33
2021
Q1
$9.35M Buy
1,712,867
+101,032
+6% +$552K 0.56% 68
2020
Q4
$6.92M Buy
1,611,835
+74,035
+5% +$318K 0.48% 89
2020
Q3
$4.63M Buy
1,537,800
+523,000
+52% +$1.57M 0.4% 102
2020
Q2
$3.15M Buy
+1,014,800
New +$3.15M 0.28% 125
2015
Q4
Sell
-360,651
Closed -$1.36M 275
2015
Q3
$1.36M Hold
360,651
0.19% 157
2015
Q2
$2.06M Hold
360,651
0.26% 143
2015
Q1
$2.1M Hold
360,651
0.26% 135
2014
Q4
$2.05M Hold
360,651
0.26% 138
2014
Q3
$1.48M Sell
360,651
-96,900
-21% -$396K 0.21% 148
2014
Q2
$2.08M Hold
457,551
0.28% 136
2014
Q1
$2.17M Hold
457,551
0.3% 132
2013
Q4
$2.15M Hold
457,551
0.29% 136
2013
Q3
$2.41M Hold
457,551
0.37% 120
2013
Q2
$2.15M Buy
+457,551
New +$2.15M 0.38% 126